Prof. Dr. Yusuf Yılmaz achieved significant success in the field of medicine by taking part in the research titled “Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis”, published in “Gut” Journal (2020 impact factor: 19.8).

This research on the diagnostic performance of non-invasive tests used to measure the presence of advanced liver fibrosis in patients with NAFLD is very important in terms of preventing unnecessary biopsy in many patients.

Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease in the world, and the prevalence of fatty liver disease in our country is estimated to be around 30%. NAFLD is also a disease that should be taken seriously as it is a disease that can cause cirrhosis.